Making A Mark In Materials Science
An Interview With In Vivo Rising Leader Jun Chen
As the leader of UCLA’s Wearable Bioelectronics Research Group, Jun Chen, assistant professor and one of In Vivo’s 2021 Rising Leaders, is deploying sensors, energy-hosting tiles, smart textiles and other technologies to tackle big problems, from health care to sustainable energy.
You may also be interested in...
A potential decline in mRNA vaccine protection against the Delta variant is raising questions about the need for booster shots in the US. Ocugen Inc. and partner Bharat Biotech hope the changing dynamic of COVID-19 in the US will induce the FDA to reconsider additional clinical trial requirements for Covaxin, an inactivated whole virus vaccine authorized for emergency use in 16 countries.
A deeper understanding of rare diseases – how they differ across geographies and ethnicities, or which genes and biomarkers are most useful targets for new treatments – can help to accelerate and de-risk clinical trials. On the commercial front, patient data and insights could mean the difference between a category leader and a failure.
Start-up pharmacy benefit managers such as Capital Rx and Evio hope to shake up the traditional PBM service model with increased drug price transparency, aggregated real-world data and outcomes-based contracting. The big three PBMs which dominate the market represent a formidable challenge.